Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Biraima-Steinemann

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Therapeutische Umschau. Revue Therapeutique|March 10, 2017
Magdalena Biraima-Steinemann, Susanne Maurer, Eliane Angst
The American Journal of Case Reports|March 30, 2026
Laparoscopic Biliary Revision for Choledocholithiasis After Roux-en-Y-Gastric Bypass: A Case Report and Discussion of Management StrategiesRobin Benhauresch, Alexander A Gogos, Bernhard Magdeburg, et al.
Obesity Surgery|February 10, 2023
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational StudyAnders Boisen Jensen, Frida Renström, Stefan Aczél, et al.
BMC Endocrine Disorders|April 8, 2025
Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational studyAnders Boisen Jensen, Ursina Machado, Frida Renström, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|March 10, 2017
Magdalena Biraima-Steinemann, Susanne Maurer, Eliane Angst
The American Journal of Case Reports|March 30, 2026
Laparoscopic Biliary Revision for Choledocholithiasis After Roux-en-Y-Gastric Bypass: A Case Report and Discussion of Management StrategiesRobin Benhauresch, Alexander A Gogos, Bernhard Magdeburg, et al.
Obesity Surgery|February 10, 2023
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational StudyAnders Boisen Jensen, Frida Renström, Stefan Aczél, et al.
BMC Endocrine Disorders|April 8, 2025
Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational studyAnders Boisen Jensen, Ursina Machado, Frida Renström, et al.
Pageof 1